妊産婦メンタルヘルス市場- 世界の産業規模、シェア、動向、機会、予測、疾患適応症別、治療法別、地域別、競合別、2020-2030年

妊産婦メンタルヘルスの世界市場は、2024年には58億3,000万米ドルとなり、2030年にはCAGR 9.23％で拡大し、新たな成長レベルに達すると予測されています。

妊産婦メンタルヘルスは、産後うつ病、不安障害、PTSDなどの症状を包含し、公衆衛生上の優先事項としてますます認識されるようになっています。これらの精神衛生上の課題は、妊娠中や産褥期に生じる可能性があり、早産や発達上の問題など、母子双方に深刻な影響を及ぼします。意識の高まり、助けを求めることの正常化、メンタルヘルスケアサービスへのアクセスの改善が、市場の成長に寄与しています。さらに、ヘルスケアプロバイダーや政策立案者は、より包括的なスクリーニングや治療戦略を導入しています。モバイルヘルスアプリ、ウェアラブル・モニタリング・デバイス、AIを活用した分析などの技術的進歩も、早期発見と個別化介入に極めて重要な役割を果たしています。世界の出生率の上昇は、意識の高まりや支援インフラと相まって、妊産婦メンタルヘルス市場の今後数年間の堅調な成長を促進すると予想されます。

市場促進要因

妊産婦メンタルヘルス疾患の高い有病率が世界の妊産婦メンタルヘルス市場を牽引

主な市場課題

スティグマと認知度

主要市場動向

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の妊産婦メンタルヘルス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 疾患別（産後うつ病、気分変調症、妊娠・産後全般不安症、妊娠・産後強迫性障害、出産関連PTSD、その他）
  • 療法（対人関係療法、抗うつ薬、認知行動療法など）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の妊産婦メンタルヘルス市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の妊産婦メンタルヘルス市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の妊産婦メンタルヘルス市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の妊産婦メンタルヘルス市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの妊産婦メンタルヘルス市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品開発
• 最近の動向

第13章 世界の妊産婦メンタルヘルス市場：SWOT分析

第14章 競合情勢

• Therapy Mama
• Canopie
• Pfizer Inc
• Viatris Inc.
• GlaxoSmithKline Inc.
• Alembic Pharmaceuticals Limited
• Mallinckrodt Inc.
• Sage Therapeutics, Inc.
• Bausch Health Companies Inc.
• Magellan Health, Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Maternal Mental Health Market was valued at USD 5.83 billion in 2024 and is projected to reach new growth levels by 2030, expanding at a CAGR of 9.23%. Maternal mental health, encompassing conditions such as postpartum depression, anxiety, and PTSD, is increasingly recognized as a public health priority. These mental health challenges can arise during pregnancy or the postpartum period and have serious implications for both mother and child, including premature birth and developmental issues. Rising awareness, the normalization of seeking help, and improved access to mental healthcare services are contributing to the market's growth. Additionally, healthcare providers and policy makers are implementing more comprehensive screening and treatment strategies. Technological advancements, including mobile health apps, wearable monitoring devices, and AI-powered analytics, are also playing a pivotal role in early detection and personalized intervention. The increasing global birth rate, coupled with heightened awareness and support infrastructure, is expected to fuel robust growth in the maternal mental health market over the coming years.

Key Market Drivers

High Prevalence of Maternal Mental Health Disorders is Driving Global Maternal Mental Health Market

The increasing recognition of the prevalence and impact of perinatal mental health disorders is a primary driver for the market. Conditions such as postpartum depression, general anxiety, and PTSD are now known to affect a substantial proportion of women during and after pregnancy. Studies indicate that up to one in seven women in the U.S. experience postpartum depression, with other regions reflecting similarly high rates. The COVID-19 pandemic further intensified maternal mental health concerns, with research from the University of Michigan highlighting that nearly one in three mothers during early 2020 experienced symptoms of depression. This growing awareness has encouraged greater demand for mental health services tailored specifically to the maternal population. Healthcare systems, non-profits, and governments are increasingly supporting maternal mental health programs, while tech firms and pharmaceutical companies are innovating around treatment and support tools, further driving market expansion.

Key Market Challenges

Stigma and Awareness

One of the major obstacles hindering market growth is the persistent stigma surrounding mental health during and after pregnancy. Many women feel pressured to conform to societal expectations that motherhood should be a purely joyful experience, leading to feelings of guilt or fear of judgment if they disclose emotional distress. As a result, many mothers delay or avoid seeking treatment altogether. Compounding this issue is the lack of consistent mental health screening in prenatal and postpartum care. To combat these barriers, efforts must focus on awareness campaigns, caregiver training, and integration of mental health checks into routine maternal care. Destigmatizing maternal mental health through education and supportive community platforms remains essential to unlocking further growth in the market.

Key Market Trends

Technological Advancements

Technology is playing a transformative role in the maternal mental health market. The rise of telehealth has made it easier for women to access care from the safety and privacy of their homes. Mobile apps designed for mood tracking, meditation, and personalized support are becoming more prevalent, offering scalable and accessible mental health solutions. Wearable technologies also support continuous monitoring of vital signs and stress indicators, enabling early detection of mental distress. Artificial Intelligence is being used to analyze behavioral and physiological data, helping predict mental health risks and guide timely interventions. Moreover, Virtual Reality is emerging as a therapeutic tool for treating postpartum anxiety and PTSD by offering immersive relaxation and exposure therapy experiences. Collectively, these technological developments are helping to reduce barriers to care, improve treatment personalization, and enhance patient engagement.

Key Market Players

• Therapy Mama
• Canopie
• Pfizer Inc
• Viatris Inc.
• GlaxoSmithKline Inc.
• Alembic Pharmaceuticals Limited
• Mallinckrodt Inc.
• Sage Therapeutics, Inc.
• Bausch Health Companies Inc.
• Magellan Health, Inc.

Report Scope:

In this report, the Global Maternal Mental Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Maternal Mental Health Market, By Disease Indication:

• Postpartum Depression
• Dysthymia
• Pregnancy and Postpartum General Anxiety
• Pregnancy and Postpartum OCD
• Birth-Related PTSD
• Others

Maternal Mental Health Market, By Therapy:

• Interpersonal Psychotherapy
• Antidepressants
• Cognitive Behavioral Therapy
• Others

Maternal Mental Health Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Maternal Mental Health Market.

Available Customizations:

Global Maternal Mental Health market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

4. Voice of Customer

5. Global Maternal Mental Health Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Disease Indication (Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, Others)
  • 5.2.2. By Therapy (Interpersonal Psychotherapy, Antidepressants, Cognitive Behavioral Therapy, others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Maternal Mental Health Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Disease Indication
  • 6.2.2. By Therapy
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Maternal Mental Health Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Disease Indication
      • 6.3.1.2.2. By Therapy
  • 6.3.2. Canada Maternal Mental Health Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Disease Indication
      • 6.3.2.2.2. By Therapy
  • 6.3.3. Mexico Maternal Mental Health Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Disease Indication
      • 6.3.3.2.2. By Therapy

7. Europe Maternal Mental Health Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Disease Indication
  • 7.2.2. By Therapy
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Maternal Mental Health Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Disease Indication
      • 7.3.1.2.2. By Therapy
  • 7.3.2. United Kingdom Maternal Mental Health Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Disease Indication
      • 7.3.2.2.2. By Therapy
  • 7.3.3. Italy Maternal Mental Health Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Disease Indication
      • 7.3.3.2.2. By Therapy
  • 7.3.4. France Maternal Mental Health Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Disease Indication
      • 7.3.4.2.2. By Therapy
  • 7.3.5. Spain Maternal Mental Health Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Disease Indication
      • 7.3.5.2.2. By Therapy

8. Asia-Pacific Maternal Mental Health Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Disease Indication
  • 8.2.2. By Therapy
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Maternal Mental Health Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Disease Indication
      • 8.3.1.2.2. By Therapy
  • 8.3.2. India Maternal Mental Health Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Disease Indication
      • 8.3.2.2.2. By Therapy
  • 8.3.3. Japan Maternal Mental Health Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Disease Indication
      • 8.3.3.2.2. By Therapy
  • 8.3.4. South Korea Maternal Mental Health Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Disease Indication
      • 8.3.4.2.2. By Therapy
  • 8.3.5. Australia Maternal Mental Health Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Disease Indication
      • 8.3.5.2.2. By Therapy

9. South America Maternal Mental Health Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Disease Indication
  • 9.2.2. By Therapy
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Maternal Mental Health Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Disease Indication
      • 9.3.1.2.2. By Therapy
  • 9.3.2. Argentina Maternal Mental Health Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Disease Indication
      • 9.3.2.2.2. By Therapy
  • 9.3.3. Colombia Maternal Mental Health Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Disease Indication
      • 9.3.3.2.2. By Therapy

10. Middle East and Africa Maternal Mental Health Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Disease Indication
  • 10.2.2. By Therapy
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Maternal Mental Health Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Disease Indication
      • 10.3.1.2.2. By Therapy
  • 10.3.2. Saudi Arabia Maternal Mental Health Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Disease Indication
      • 10.3.2.2.2. By Therapy
  • 10.3.3. UAE Maternal Mental Health Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Disease Indication
      • 10.3.3.2.2. By Therapy

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition
• 12.2. Product Development
• 12.3. Recent Developments

13. Global Maternal Mental Health Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Therapy Mama
  • 14.1.1. Business Overview
  • 14.1.2. Application Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Key Personnel
  • 14.1.5. SWOT Analysis
• 14.2. Canopie
• 14.3. Pfizer Inc
• 14.4. Viatris Inc.
• 14.5. GlaxoSmithKline Inc.
• 14.6. Alembic Pharmaceuticals Limited
• 14.7. Mallinckrodt Inc.
• 14.8. Sage Therapeutics, Inc.
• 14.9. Bausch Health Companies Inc.
• 14.10. Magellan Health, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer